Panacea Biotec Ltd share price logo

Panacea Biotec Share Price

NSE: PANACEABIO

BSE: 531349

Small Cap

Healthcare Sector

₹423.80

16.50

(4.05%) ▲

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Advanced Chart

Panacea Biotec Stock Performance

as on September 3, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹407.3
    ₹432.4
    downward going graph

    3.89%

    Downside

    2.03%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹220
    ₹581.9
    downward going graph

    48.09%

    Downside

    37.31%

    Upside

    downward going graph

Panacea Biotec share price movements today

Previous Close
₹407.30
Open
₹407.30
Volume
2.70L
Upper Circuit
₹488.75
Lower Circuit
₹325.85
Day's Low - High
₹407.3 - ₹432.4
52 Week Low - High
₹220 - ₹581.9

Panacea Biotec Historical Returns

1 Month Return
-1.12 %
3 Month Return
-14.93 %
1 Year Return
+ 74.78 %
3 Year Return
+ 191.55 %
5 Year Return
+ 132.98 %

Panacea Biotec Fundamentals

as on September 3, 2025 at 4:01 pm IST

Market Cap

₹2,494.74 Cr

Return on Equity (ROE)

0.86

PE Ratio (TTM)

218.98

Return on capital employed (ROCE)

3.26

Industry PE ratio

42.24

Beta (LTM)

0.88

P/B Ratio

2.42

Dividend Yield

0

PEG Ratio

34.22

Quarterly Earnings Growth YOY

-124.94

EPS (TTM)

-0.25

Sector

Pharmaceuticals

Book Value

133.94

Technical Analysis

Bullish

View Technical Analysis

Panacea Biotec Stock Valuation

as on September 3, 2025 at 4:01 pm IST

Panacea Biotec in the last 5 years

  • Overview

  • Trends

Lowest (-915.62x)

April 25, 2024

Industry (42.24x)

September 2, 2025

Today (218.98x)

September 2, 2025

Highest (235.24x)

July 17, 2025

LowHigh

Today’s Price to Earnings Ratio: 218.98x

Panacea Biotec Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Panacea Biotec with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Panacea Biotec Ltd image
Panacea Biotec Ltd
NA2,494.7426.6%0.53-2559
Alpa Laboratories Ltd image
Alpa Laboratories Ltd
NA201.9748.44%0.5216108
Kerala Ayurveda Ltd image
Kerala Ayurveda Ltd
NA548.20129.03%0.85-1107
Lincoln Pharmaceuticals Ltd image
Lincoln Pharmaceuticals Ltd
NA1,113.8526.81%0.5093580
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,194.102252.5%0.001874
See all

Panacea Biotec Stock's Interest Amongst Investors

Search interest for Panacea Biotec Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Panacea Biotec Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
105.12
115.2
128.93
129.19
143.02
150.5
136.46
115.72
147.35
163.49
132.53
166.7
Other Income
38.22
41.71
34.44
33.82
6
8.46
13.55
6.54
7.42
6.39
36.3
16.99
Total Income
143.34
156.91
163.37
163.01
149.02
158.96
150.01
122.26
154.77
169.88
168.83
183.69
Expenses
108.96
123.84
134.6
139.5
146.58
150.65
142.5
129.71
140.35
155.53
159.41
167.88
Operating Profit
-3.84
-8.64
-5.67
-10.31
-3.56
-0.15
-6.04
-13.99
7
7.96
-26.88
-1.18
Operating Profit Margin %
-3.65%
-7.5%
-4.4%
-7.98%
-2.49%
-0.1%
-4.43%
-12.09%
4.75%
4.87%
-20.28%
-0.71%
Profit Before Interest, Tax and Depreciation
34.38
33.07
28.77
23.51
2.44
8.31
7.51
-7.45
14.42
14.35
9.42
15.81
Interest
1.18
0.96
1.05
1
0.91
0.85
0.82
0.87
0.98
0.99
1.04
0.86
Depreciation
9.89
9.67
9.51
9.48
9.31
9.11
8.81
8.73
8.68
8.98
8.42
8.39
Profit Before Tax
23.31
22.44
18.21
13.03
-7.78
-1.65
-2.12
-17.05
4.76
4.38
-0.04
6.56
Tax Paid
7.61
3.07
30.89
2.05
0.51
0.55
-0.13
-1.17
0.05
-0.06
1.95
2.6
Profit After Tax
15.7
19.37
-12.68
10.98
-8.29
-2.2
-1.99
-15.88
4.71
4.44
-1.99
3.96
Total Net profit including share of profit / Loss from associate company
15.7
19.37
-12.68
10.98
-8.29
-2.2
-1.99
-15.88
4.71
4.44
-1.99
3.96
EPS
2.56
3.16
-2.03
1.79
-1.35
-0.37
-0.23
-2.59
0.77
0.74
-0.31
0.66
Actual EPS
2.56
3.16
-2.03
1.79
-1.35
-0.37
-0.23
-2.59
0.77
0.74
-0.31
0.66
Adjusted EPS
2.56
3.16
-2.03
1.79
-1.35
-0.37
-0.23
-2.59
0.77
0.74
-0.31
0.66
Diluted EPS
2.56
3.16
-2.03
1.79
-1.35
-0.37
-0.23
-2.59
0.77
0.74
-0.31
0.66

Panacea Biotec Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
544.01
592.79
456.7
544.06
624.81
661.23
459.95
559.17
559.09
Other Income
54.58
7.99
338.64
30.02
10.06
1,687.18
154.32
61.83
56.65
Total Income
598.59
600.78
795.34
574.08
634.87
2,348.41
614.27
621
615.74
Expenses
496.89
509.06
591.13
534.53
549.62
675.09
557.91
579.23
585
Operating Profit
47.12
83.73
-134.43
9.53
75.19
-13.86
-97.96
-20.06
-25.91
Operating Profit Margin %
8.66%
14.12%
-29.44%
1.75%
12.03%
-2.1%
-21.3%
-3.59%
-4.63%
Profit Before Interest, Tax and Depreciation
101.7
91.72
204.21
39.55
85.25
1,673.32
56.36
41.77
30.74
Interest
100.93
100.58
104.83
173.98
185.34
180.84
4.44
3.58
3.88
Depreciation
67.95
57.28
54
43.22
45.6
43.66
39.12
36.71
34.81
Profit Before Tax
-67.18
-66.14
45.38
-177.65
-145.69
1,448.82
12.8
1.48
-7.95
Tax Paid
-10.98
9.86
7.71
16.64
1.96
370.91
46.55
2.98
0.77
Profit After Tax
-56.2
-76
37.67
-194.29
-147.65
1,077.91
-33.75
-1.5
-8.72
Total Net profit including share of profit / Loss from associate company
-56.2
-76
37.67
-194.29
-147.65
1,077.91
-33.75
-1.5
-8.72
EPS
-6.68
-12.41
6.15
-31.72
-24.11
175.98
-5.43
-0.19
-1.37
Actual EPS
-6.68
-12.41
6.15
-31.72
-24.11
175.98
-5.43
-0.19
-1.37
Adjusted EPS
-6.13
-11.39
5.64
-29.1
-24.11
175.98
-5.43
-0.19
-1.37
Diluted EPS
-6.68
-12.41
6.15
-31.72
-24.11
175.98
-5.43
-0.19
-1.37

Panacea Biotec Ltd Cash Flow

Figures in Rupees Crores

Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
37.23
90.69
130.66
118.02
104.8
-30.47
106.76
-108.45
-422.45
-0.1
Cash Flow from Investing Activities
-37.38
16.45
-25.85
55.29
-5.62
-34.52
-47.79
1,282.56
430.32
10.23
Cash Flow from Financing Activities
-0.7
-117.38
-106.96
-164.35
-101.14
90.73
-47.12
-1,175.85
-18.37
-2.81
Net Cash Flow
-0.85
-10.24
-2.13
8.97
-1.97
25.75
11.86
-1.74
-10.5
7.32

Panacea Biotec Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
73.59%
73.59%
73.59%
73.59%
73.59%
73.59%
73.59%
73.46%
72.87%
72.49%
72.48%
72.48%
DII
0.29%
0.43%
0.43%
0.54%
0%
0%
0.84%
1.07%
1.16%
1.17%
1.49%
1.52%
FII
0%
0%
0%
0%
0%
0%
0.27%
0.27%
0.37%
0.38%
1.16%
0.78%
Public
25.98%
25.8%
25.8%
25.66%
25.58%
25.46%
25.3%
25.2%
25.6%
25.97%
24.86%
25.22%
Total Outstanding Shares
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
6,12,50,746
Total Shareholders
49,078
50,533
48,634
47,815
48,878
47,091
46,242
45,513
39,982
35,446
33,593
34,256

Panacea Biotec Earnings and Dividends

View detailed summary of the earnings and dividend history of Panacea Biotec.

  • Panacea Biotec Ltd Earnings Results

    Panacea Biotec Ltd’s net profit jumped 125.63% since last year same period to ₹4.05Cr in the Q1 2025-2026. On a quarterly growth basis, Panacea Biotec Ltd has generated 314.29% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Panacea Biotec Ltd Dividends May,2011

    In the quarter ending March 2011, Panacea Biotec Ltd has declared dividend of ₹0.75 per share on 13 May 2011 - translating a dividend yield of 0.18%.

    Read More about Dividends

Insights on Panacea Biotec Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, PANACEABIO stock has moved up by 74.8%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 24.86% to 25.22% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.89 Cr → 4.05 Cr (in ₹), with an average increase of 146.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 168.83 Cr → 183.69 Cr (in ₹), with an average increase of 8.1% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.48% of holdings in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.16% to 0.78% in Jun 2025 quarter

About Panacea Biotec Ltd

Panacea Biotec Limited (PBL), India’s leading research-based health management company, originated in 1984 and since then has grown to become the nation’s second largest vaccine producer. Its wide range of products include innovative prescription drugs across therapeutic areas such as diabetes, renal disease, gastrointestinal, osteoporosis and antituberculosis. The company owns a number of ultra-modern, state-of-the-art production facilities that comply with USFDA, UKMHRA, SAMCA and WACGMP standards as well as four research and development centers. These are supported by collaborations and tie-ups with global industry leaders. To date, PBL owns 24 product patents valid in more than 60 countries and has forged landmark agreements on an international level. Recent collaborations include Netherland's Vaccine Institute, PT Bio Farma, The National Institute of Immunology, National Institute of Health, and Punjab University. Besides manufacturing and marketing, the company is involved in healthcare delivery, with a 220-bed multispecialty hospital, and holds a number of product patents in the US and India. PBL's step down subsidiaries Radhika Heights Limited and its subsidiaries were demerged into RVHL in 2020 and the Pharmaceutical Formulations Brands of PBPL in India and Nepal were sold to Mankind Pharma Limited in 2022. This strategic approach positions PBL at the forefront of global health management.

Revenue: ₹166.70Cr as on June 2025 (Q1 FY26)
Net Profit: ₹3.96Cr as on June 2025 (Q1 FY26)
Listing date: 17 Apr, 1996
Chairperson Name: Rajesh Jain
OrganisationPanacea Biotec Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORajesh Jain
E-voting on sharesClick here to vote

FAQs

What is Panacea Biotec share price today?

Panacea Biotec share price today stands at ₹423.8 as on at the close of the market. Panacea Biotec share today touched a day high of ₹432.4 and a low of ₹407.3.

What is the 52 week high and 52 week low range for Panacea Biotec share?

Panacea Biotec touched a 52 week high of ₹581.9 and a 52 week low of ₹220. Panacea Biotec share price today i.e. is closed at ₹423.8, which is -27.17% down from its 52 week high and 92.64% up from its 52 week low.

What is Panacea Biotec's market capitalisation today?

Panacea Biotec market capitalisation is ₹2,494.74 Cr as on .

How to buy Panacea Biotec shares?

To buy Panacea Biotec shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PANACEABIO or Panacea Biotec Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Panacea Biotec shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Panacea Biotec trading volume today?

Panacea Biotec trading volume is 2.70L as on . This means that 2.70L shares of Panacea Biotec were bought and sold on the stock market during today's trading session.